Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
More News

Li-Cor Biosciences

Facebook Twitter LinkedIn Email Comments
Li-Cor Biosciences of Lincoln, Neb., and Spectros Corp. of Portola Valley, Calif., have announced a nonexclusive licensing and supply agreement to couple the former company’s IRDye 800CW to the latter’s targeted biomarkers. Additionally, the companies have agreed to develop targeted fluorescent contrast agents for real-time imaging and treatment of prostate and ovarian cancer.

Feb 2010
The emission of light or other electromagnetic radiation of longer wavelengths by a substance as a result of the absorption of some other radiation of shorter wavelengths, provided the emission continues only as long as the stimulus producing it is maintained. In other words, fluorescence is the luminescence that persists for less than about 10-8 s after excitation.
agentsAmericasbiomarkersBiophotonicsBusinesscancerfluorescenceFluorescent Contrast AgentsimagingIRDye 800CWLi-Cor Bioscienceslicensingovarian cancerprostateRapidScanreal-time imagingSpectros agreement

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.